Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-09-25

FDA Approved: JUNEL 21 DAY — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for JUNEL 21 DAY (norethindrone acetate and ethinyl estradiol) from Teva Pharmaceuticals USA, indicating an approved…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Junel 21 Day (NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL)

Snippet

SUPPL AP for JUNEL 21 DAY (NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL)